Rooted in science and nature, we help you optimize your routine and cultivate a more balanced, mindful life. We offer discreet shipping and comprehensive information on safe usage.
We’re a Dutch company on a mission to bring clarity and focus into everyday life through legal psychedelics and mindful wellness tools.
As two young professionals, we discovered microdosing as a way to cut through the noise, sharpen our focus, and feel more present in our daily routines.
Psychedelics, when used responsibly, have shown remarkable potential not just for enhancing productivity and creativity but also for addressing mental health challenges.
Research from leading institutions, such as Johns Hopkins University¹, Imperial College London², NYU Langone Health³, King’s College London⁴, and UCLA⁵, has demonstrated promising results in the use of psilocybin and other psychedelics to help alleviate symptoms of depression, PTSD, and anxiety.
Moreover, ongoing studies from UC San Diego⁶, Yale⁷, and Harvard Medical School⁸ are uncovering the potential of psychedelics in slowing cognitive decline, enhancing neuroplasticity, and restructuring neural pathways associated with emotional regulation and memory. These discoveries are shaping a future in which psychedelics could be integrated into mainstream approaches to mental and neurological health.
Our goal is to provide safe, legal, and carefully curated tools that empower individuals to optimize their routines, find moments of calm, and reconnect with themselves.
Whether you’re exploring microdosing for greater focus or seeking a more profound, mindful trip with bigger packages, we’re here to support you every step of the way.
¹ Johns Hopkins Medicine. (2022, February 15). Psilocybin treatment for major depression effective for up to a year for most patients, study shows.
² Carhart-Harris, R. L., et al. (2018). Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up. Scientific Reports, 7, 13164.
³ Ross, S., et al. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer. Journal of Psychopharmacology, 30(12), 1165–1180.
⁴ Rucker, J. J., Iliff, J., & Nutt, D. J. (2021). Psychiatry & the psychedelic drugs. Journal of Psychopharmacology, 35(4), 351–355.
⁵ UCLA Health. (2023, June 12). Do psychedelics have a role in psychiatric treatment?
⁶ UC San Diego News Center. (2023, February 10). The psychedelic revolution is coming. Psychiatry may never be the same.
⁷ Yale School of Medicine. (n.d.). Yale Program for Psychedelic Science.
⁸ Massachusetts General Hospital. (n.d.). Center for the Neuroscience of Psychedelics.